P-165 First-line treatment with CET/PAN vs. BEV in elderly patients with RAS WT mCRC: A multicenter real-world observational study by the Japanese Society for Cancer of the Colon and Rectum

K Yamamoto ,Naotoshi Sugimoto ,Kengo Nagashima ,Hiroyuki Uetake ,Yasumasa Takii ,Toshikazu Moriwaki ,Masahiro Goto ,Masahiro Tsuda ,K Yamazaki ,Ryoichi Sawada ,Kazuo Shinozaki ,Atsuo Takashima ,Takeshi Suto ,Akihito Tsuji ,Hiroki Yukami ,Toshiharu Hirose ,Hisateru Yasui ,Satoshi Otsu ,Taito Esaki ,Hitoshi Ojima ,Yôko Shimada

doi:10.1016/j.annonc.2023.04.221

P-165 First-line treatment with CET/PAN vs. BEV in elderly patients with RAS WT mCRC: A multicenter real-world observational study by the Japanese Society for Cancer of the Colon and Rectum

K Yamamoto , Naotoshi Sugimoto + Show 19 more

Open Access

https://doi.org/10.1016/j.annonc.2023.04.221

Copy DOI

Journal: Annals of Oncology

Publication Date: Jun 1, 2023

Affiliation: National Cancer Center Hospital East, Osaka International Cancer Institute, Keio University Hospital, Tokyo Medical and Dental University, Niigata Cancer Center Hospital, University of Tsukuba, Hyogo Prefectural Cancer Center, Shizuoka Cancer Center, Jikei University School of Medicine, Hiroshima Prefectural Hospital, Yamagata Prefectural Central Hospital, Kobe City Medical Center General Hospital, Oita University

#RAS WT mCRC #Multicenter Real-world Study + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

P-165 First-line treatment with CET/PAN vs. BEV in elderly patients with RAS WT mCRC: A multicenter real-world observational study by the Japanese Society for Cancer of the Colon and Rectum

Full Text

Paper version not known

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Annals of Oncology

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.